APA

Kishnani P. S., DiRocco M., Kaplan P., Mehta A., Pastores G. M., Smith S. E., Puga A. C., Lemay R. M. & Weinreb N. J. (20090515). A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1. : Molecular genetics and metabolism.

Chicago

Kishnani P S, DiRocco M, Kaplan P, Mehta A, Pastores G M, Smith S E, Puga A C, Lemay R M and Weinreb N J. 20090515. A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1. : Molecular genetics and metabolism.

Harvard

Kishnani P. S., DiRocco M., Kaplan P., Mehta A., Pastores G. M., Smith S. E., Puga A. C., Lemay R. M. and Weinreb N. J. (20090515). A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1. : Molecular genetics and metabolism.

MLA

Kishnani P S, DiRocco M, Kaplan P, Mehta A, Pastores G M, Smith S E, Puga A C, Lemay R M and Weinreb N J. A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1. : Molecular genetics and metabolism. 20090515.